Literature DB >> 17845329

Clinical, endocrine and ultrasonographic features of polycystic ovary syndrome in Thai women.

Teraporn Vutyavanich1, Vorathep Khaniyao, Supreeya Wongtra-Ngan, Opas Sreshthaputra, Rungaroon Sreshthaputra, Waraporn Piromlertamorn.   

Abstract

AIM: To study the prevalence, reproductive hormone profiles and ovarian sonographic appearance of Thai women with polycystic ovary syndrome (PCOS).
METHODS: One thousand and ninety-five women were screened for oligomenorrhea/amenorrhea, and the clinical symptoms of hyperandrogenism. Ovarian morphology and volume were assessed by ultrasonography in diagnosed cases. Blood was taken for the measurement of the follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, androstenedione, dehydroepiandrosterone and 17-hydroxyprogesterone.
RESULTS: The prevalence of PCOS was 5.7%. The mean age of women with PCOS was less than that of non-PCOS cases (27.4 +/- 6.5 and 31.1 +/- 6.4 years, respectively; P < 0.0001). Abnormal uterine bleeding and infertility were the leading presenting symptoms. The mean ovarian volume in women with PCO appearance was 9.22 +/- 4.36 mL compared to 6.53 +/- 3.31 mL in those without this appearance (P = 0.04). Hyperandrogenemia was confirmed in 23 of the 62 cases (37.1%).
CONCLUSIONS: The prevalence and clinical presentations of Thai women with PCOS were similar to those in other reports. However, hirsutism, elevated testosterone level and acanthosis nigricans were uncommon in our population. Serum androstenedione was a more sensitive indicator of hyperandrogenemia than total testosterone. Further research is needed to clarify whether there is an ethnic difference in endocrine profiles and risks of metabolic syndrome.

Entities:  

Mesh:

Year:  2007        PMID: 17845329     DOI: 10.1111/j.1447-0756.2007.00631.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  5 in total

1.  Predictors of Depression in Iranian Women with Polycystic Ovarian Syndrome.

Authors:  Mojgan Mirghafourvand; Sakineh Mohammad-Alizadeh Charandabi; Tahereh Behroozi Lak; Fatemeh Aliasghari
Journal:  Community Ment Health J       Date:  2017-11-14

2.  Sexual function and hormonal profiles in women with and without polycystic ovary syndrome: a population-based study.

Authors:  M Noroozzadeh; F Ramezani Tehrani; S Sedigh Mobarakabadi; M Farahmand; M Rostami Dovom
Journal:  Int J Impot Res       Date:  2016-09-22       Impact factor: 2.896

3.  Standardised versus individualised multiherb Chinese herbal medicine for oligomenorrhoea and amenorrhoea in polycystic ovary syndrome: a randomised feasibility and pilot study in the UK.

Authors:  Lily Lai; Andrew Flower; Philip Prescott; Trevor Wing; Michael Moore; George Lewith
Journal:  BMJ Open       Date:  2017-02-03       Impact factor: 2.692

4.  Molecular docking and mouse modeling suggest CMKLR1 and INSR as targets for improving PCOS phenotypes by minocycline.

Authors:  Mahdie Kian; Elham Hosseini; Tooba Abdizadeh; Taimour Langaee; Azadeh Khajouei; Sorayya Ghasemi
Journal:  EXCLI J       Date:  2022-02-16       Impact factor: 4.068

5.  Follicle-stimulating hormone receptor gene polymorphism in chronic anovulatory women, with or without polycystic ovary syndrome: a cross-sectional study.

Authors:  Wanakan Singhasena; Tawiwan Pantasri; Waraporn Piromlertamorn; Sudarat Samchimchom; Teraporn Vutyavanich
Journal:  Reprod Biol Endocrinol       Date:  2014-09-02       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.